Tuberculosis

Isoniazid, also known as isonicotinylhydrazide (INH), is an antibiotic used as a first-line agent for the prevention and treatment of both latent and active tuberculosis.

Pyrazinamide is a drug used to treat tuberculosis.

Rifampicin, also known as rifampin, is an antibiotic used to treat a several types of bacterial infections.

Capreomycin is a antibiotic which is given in combination with other antibiotics for MDR-tuberculosis.

Pretomanid (PA-824) is an experimental anti-tuberculosis drug.

Bacillus Calmette–Guérin (BCG) vaccine is a vaccine primarily used against tuberculosis.

Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis (MTB).

World Tuberculosis Day, falling on March 24 each year, is designed to build public awareness about the global epidemic of tuberculosis (TB) and efforts to eliminate the disease.

A paronychia (/ˌpærəˈnɪkiə/; Greek: παρωνυχία from para, "around" and onukh-, "nail") is a nail disease that is an often-tender bacterial or fungal infection of the hand or foot where the nail and skin meet at the side or the base of a finger or toenail.

A sanatorium (also spelled sanitorium and sanitarium) is a medical facility for long-term illness, most typically associated with treatment of tuberculosis (TB) before antibiotics.

4-Aminosalicylic acid (para-aminosalicylic acid or PAS) is an antibiotic used to treat tuberculosis.

Ethambutol (commonly abbreviated EMB or simply E) is a medication primarily used to treat tuberculosis.

Miliary tuberculosis is a form of tuberculosis that is characterized by a wide dissemination into the human body and by the tiny size of the lesions (1–5 mm).

SQ109 is a drug undergoing development for treatment of tuberculosis.

Streptomycin is an antibiotic (antimycobacterial) drug, the first of a class of drugs called aminoglycosides to be discovered, and it was the first effective treatment for tuberculosis.

Mycobacterial cervical lymphadenitis, also known as scrofula or King's evil, refers to a lymphadenitis of the cervical lymph nodes associated with tuberculosis as well as non-tuberculous (atypical) mycobacteria.

Bedaquiline (trade name Sirturo) is a medication used to treat tuberculosis.

Cycloserine (4-amino-3-isoxazolidinone) is an amino acid derivative with an unusual structure.

A diagnosis of latent tuberculosis (LTB), also called latent tuberculosis infection (LTBI) means a patient is infected with Mycobacterium tuberculosis, but the patient does not have active tuberculosis.

Thioacetazone (INN and BAN) is also called thiocetazone, thiacetazone, thiosemicarbazone, benzothiozane or amithiozone (USAN); abbreviated T.

Tuberculous lymphadenitis (or tuberculous adenitis) is a chronic specific granulomatous inflammation of the lymph node with caseation necrosis, caused by infection with Mycobacterium tuberculosis or Mycobacterium bovis.

ESAT-6, the 6 kDa early secretory antigenic target produced by Mycobacterium tuberculosis, is a secretory protein and potent T cell antigen.

Delamanid (USAN, INN) is a drug for the treatment of multi-drug-resistant tuberculosis.

A tuberculoma is a clinical manifestation of tuberculosis which conglomerates tubercles into a firm lump, and so can mimic cancer tumors of many types in medical imaging studies.

Tuberculous dactylitis is a skeletal manifestation of tuberculosis.

Lupus vulgaris (also known as Tuberculosis luposa) are painful cutaneous tuberculosis skin lesions with nodular appearance, most often on the face around the nose, eyelids, lips, cheeks, ears and neck.

Tuberculosis verrucosa cutis (also known as "lupus verrucosus", "prosector's wart", and "warty tuberculosis") is a rash of small, red papular nodules in the skin that may appear 2–4 weeks after inoculation by Mycobacterium tuberculosis in a previously infected and immunocompetent individual.

Tuberculous meningitis is also known as TB meningitis or tubercular meningitis.

Multi-drug-resistant tuberculosis (MDR-TB, also known as Vank's disease) is defined as a form of TB infection caused by bacteria that are resistant to treatment with at least two of the most powerful first-line anti-TB drugs, isoniazid (INH) and rifampicin (RMP).

Rifalazil (also known as KRM-1648 and AMI-1648) is an antibiotic.

Tuberculin is an extract of Mycobacterium tuberculosis, M.

Rifampicin/isoniazid/pyrazinamide (trade name Rifater) is a fixed dose combination tablet manufactured by Aventis used in the treatment of tuberculosis.

Neothetazone is an antibiotic combination of methaniazide (neotizide) and thioacetazone that is or was very commonly used in the treatment of tuberculosis.